A new MRR1 gain-of-function mutation involved in cross-resistance to antifungal agents in the fungal priority pathogen Candida parapsilosis.

Cresemba (isavuconazonium sulfate) - Astellas, Basilea

voriconazole - Generic mfg.

Noxafil (posaconazole) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42696756

Alina Marcela-Sabou; Estelle Robert; Florent Morio; Isabelle Ourliac-Garnier; José Rivaldo De Lima; Manon Cadeau; Patrice Le Pape

Sep 5, 2026